← Eichor
Condition: Retinal Neovascularization Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Retinal Neovascularization

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MMP-9 Inhibition for Recalcitrant Wet AMD
Phase 2 · 1 location(s) · University of Iowa · NCT04504123Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2/Phase 3 · 1 location(s) · Isfahan University of Medical Sciences · NCT06595355Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degener
Phase N/A · 1 location(s) · Saglik Bilimleri Universitesi · NCT07235527A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · 91 location(s) · EyeBiotech Ltd. · NCT07440225Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal
Phase 3 · 1 location(s) · Yeungnam University College of Medicine · NCT07461441Effect of Video Viewing on Intravitreal Injection Experience
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07002372Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy
NA · 6 location(s) · Xiamen Ophthalmology Center Affiliated to Xiamen University · NCT07586787Biomarkers and Choroidal Neovascularization
Phase N/A · 2 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04439708OCT in Rare Chorioretinal Diseases
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT02141308Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Phase 3 · 181 location(s) · AbbVie · NCT05407636Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · 94 location(s) · 4D Molecular Therapeutics · NCT07064759A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Phase 2/Phase 3 · 63 location(s) · EyeBiotech Ltd. · NCT07496567AVIGA3 (Cohort 2.0)
NA · 1 location(s) · Tan Tock Seng Hospital · NCT07255859
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.